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Abstract.
Background: Free-living or habitual physical activity (HPA) refers to someone’s performance in his or her free-living
environment. Neuromuscular disorders (NMD) manifest through HPA, and the observation of HPA can be used to identify
clinical risks and to quantify outcomes in research. This review summarizes and analyses previous studies reporting the
assessment of HPA in NMD, and may serve as the basis for evidence-based decision-making when considering assessing
HPA in this population.
Methods: A systematic review was performed to identify all studies related to HPA in NMD, followed by a critical appraisal
of the assessment methodology and a final review of the identified HPA tools.
Results: A total of 22 studies were selected, reporting on eight different direct tools (or activity monitors) and ten structured
patient-reported outcomes. Overall, HPA patterns in NMD differ from healthy control populations. There was a noticeable
lack of validation studies for these tools and outcome measures in NMD. Very little information regarding feasibility and
barriers for the application of these tools in this population have been published.
Conclusions: The variety and heterogeneity of tools and methods in the published literature makes the comparison across
different studies difficult, and methodological guidelines are warranted. We propose a checklist of considerations for the
assessment and reporting of HPA in NMD.
Keywords: Physical activity, daily activity, exercise, activity monitor, neuromuscular disorders, muscular dystrophy
INTRODUCTION
New technology has been developed over the last
decade that is able to monitor and measure daily life
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activity behaviour, generating a large amount of data
for analysis and mass-market applications. Increas-
ingly, this technology has been implemented into
research and many of these tools have been correlated
to long-term health outcomes and motor capacity in
diseases with impaired mobility such as Parkinson’s
disease [1], stroke [2] and cerebral palsy [3].
Patients with neuromuscular disorders (NMD) fre-
quently experience limitations caused by muscle
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weakness, pain, fatigue, reduced mobility and overall
functionality, all of which result in a limited partic-
ipation in activities of daily living and a sedentary
lifestyle with its associated risks [4–8]. Consequently,
the need for further research has been emphasized
with the goal of analysing and improving physical
activity (PA) safely and developing evidence-based
exercise recommendations [5, 9, 10]. However, the
rareness and heterogeneity of NMDs [11], have
resulted in relatively few clinical trials utilizing this
technology and there is still a lack of awareness of
the potential of this as an outcome measure and it is
still unclear which tool may be most appropriate in
which setting [12, 13].
Assessing free-living or habitual physical activity
Free-living or habitual physical activity (HPA)
encompasses any activity that people do in their daily
life and natural environment. HPA qualifies as an out-
come of performance rather than capacity, as it refers
to someone’s involvement and real participation in
daily-life activities (DLA) rather than their ability to
execute an action (usually tested in clinic, i.e. under
request and ideal circumstances) [14, 15]. Important
outcomes associated with HPA patterns are survival
and disease progression; however, a more immediate
benefit of a healthy HPA behaviour would be quality
of life [16].
Assessing someone’s HPA is essential to: [1] deter-
mine whether altered activity behaviours are present;
[2] establish an appropriate dose of PA to impact on
specific health parameters; [3] set measurable goals
for PA-related interventions; and [4] establish a sur-
rogate outcome measure for clinical trials [17–22].
In research, HPA can be measured either directly
or indirectly. Indirect tools refer to patient-reported
outcomes (PRO) such as questionnaires and activity
diaries, which are often simple to apply, cost-efficient
and a good option for large cohort studies. However,
PRO are susceptible to subjectivity and bias related to
self-reporting and/or interpretation usually requiring
larger sample sizes when assessing changes over time
or differences between groups [23, 24]. Nonetheless,
regulatory agencies have acknowledged the impor-
tance of PRO in drug development and marketing
approval as long as these come with enough evidence
to validate their reliability [25]. To validate an indi-
rect tool objectively, it should be compared to a direct
tool.
Direct methods, on the other hand, assess actual
physiological changes; these can be: physiologi-
cal markers (e.g. heart rates), motion sensors (e.g.
pedometers or accelerometers) or calorimeters (e.g.
doubly labelled water method) that correlate with
physical activity. Direct tools are considered more
objective and accurate [26, 27]; however, these also
present limitations [28, 29]. They are typically more
expensive, time-consuming and tend to place a higher
burden on the researcher and the participant [17, 28,
30, 31]. Additionally, the most common outputs of
these devices rely on the manufacturers’ algorithmic
estimations and cannot always be generalizable to
the target population and the raw data’s full interpre-
tation still depends upon the researcher’s experience
[32]. Doubly labelled water is the gold standard for
the other tools to validate Energy Expenditure (EE)
estimations, currently. Observation is the standard
method to validate type-of-activity detection (i.e.
steps) [27].
There is yet no gold standard tool for assessing
HPA in NMD and the adaptation of any of these tools
into clinical practice and research is not straightfor-
ward. Future application in clinical practice requires
further research to confirm the validity and reliabil-
ity of tools in the particular population being studied
[33–38]. A good start for this is to learn from previous
experiences [1–3, 33–35].
Review aims
The aim of this review was to identify and anal-
yse the tools and methodology previously used to
assess HPA in NMD. To accomplish this, studies in
NMD that reported any type of HPA assessment were
selected and reviewed. Any HPA tools and method-
ologies used were identified and critically analysed.
Finally, we conclude with an evidence-based check-
list of interest to researchers and clinicians measuring
HPA in NMD.
This review’s protocol was initially registered with
the PROSPERO (International prospective register of
systematic reviews) database [39].
METHODS
Search methodology
A systematic literature search was carried out
through the following databases: EMBASE; MED-
LINE; and PsychINFO. The search strategy was to
retrieve literature that investigated the use of free-
living (habitual) activity assessment tools used in
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Table 1
Direct HPA-tools report – methodological variables for analysis
Area of Consideration Variable reviewed Definition
MONITOR CHARACTERISTICS Activity monitor Device manufacturer and model.
Body location Placement location of device.
DATA COLLECTION Wear period Requested days or time to wear the device.
Number of hours per day Number of hours per day requested to be used. Identification
whether worn full-time or just worn whilst awake.
DATA MANAGEMENT Number of valid days Number of days of data considered for the analysis. Criteria
for days excluded.
Definition of non-wear period Specific criteria to identify a non-worn device.
Missing data methodology Methodology and criteria to handle missing data.
DATA ANALYSIS Endpoints analysed and reported PA measurement(s) used, definition(s) and units presented.
OTHERS Quality assurance tool Information about any additional tool used for quality
control – i.e. to verify activity or non-activity periods
detected by the device.
Methodology Reference Inclusion of references to any prediction values.
Classification method used or directly to device developer.
NMD. Hence the search used identified keywords
from each database as appropriate. Terms included
“free living activity”, “performance”, “physical activ-
ity”, and “daily life activity” in combination with
“neuromuscular disease(s)”, “neuromuscular dis-
order(s)”, “muscle disease(s)” and/or “muscular
dystrophy”.
Study selection
The search included publications from 1996 until
the end date of search (March 2016).
Papers fulfilling the following criteria were
included for analysis: [1] participants diagnosed with
genetic neuromuscular disorders (NMD); [2] utilised
measurement tools for habitual physical activity
(HPA) assessing the subject’s performance for at least
24 successive hours; [3] patient-reported outcomes
should include at least 60% items related to HPA.
Publications were excluded when they: [1] were not
published in English; [2] were single cases, on-going
studies, non-research reports, conference abstracts or
pre-clinical studies; [3] measured “capacity” or “life
participation” instead of HPA “performance” or were
of use only in controlled laboratory environments
[14, 40].
The titles and abstracts of all retrieved references
were screened by one reviewer (AJ) to exclude papers
that did not instantly fulfil the inclusion criteria.
Publications selected were properly revised by two
independent reviewers (AJ, JN) to verify the selec-
tion criteria. Conflicting viewpoints and exclusion
decisions were discussed with a third reviewer (SC)
until a consensus was reached. Finally, the three
main reviewers (AJ, JN, SC) proceeded with a deep
analysing and summarising of the final selection of
papers. After that, all HPA-tools identified were sub-
sequently labelled as a patient’s (or next of kin)
reported outcome (PRO) or as a direct tool (D).
1. Summary of direct HPA tools
The variables analysed are presented in Table 1.
This review methodology follows criteria which
adhere to the methods proposed by Matthews et al. of
‘Best Practices for Using Physical Activity Monitors
in Population-Based Research’ [41]. When more than
two variables were missing on the report, an attempt
was made to contact the study authors by email.
2. Summary of indirect HPA tools
Patient-reported outcomes (e.g. questionnaires or
PA diaries) were analysed by the identification of:
[1] tool utilised; [2] data collection: respondent (i.e.
patient, carer, etc.); location of completion (i.e. clini-
cal settings, home, etc.); recollection method (i.e. face
to face, phone, post, online, etc.); [3] data analysis
criteria and methodology; [4] endpoints reported.
RESULTS
Study selection
The results of the literature and selection processes
are displayed in Fig. 1. The initial search yielded
1,070 titles and abstracts from which 88 were selected
using the predefined criteria, a good number of these
refer to a physical activity or an exercise parameter
different from HPA as defined previously. Of these,
the second double-peered filter excluded 67 papers.
Four conference abstracts and three on-going stud-
ies with published protocols were excluded at this
stage [42–48]. One paper included only a minor num-
ber of patients with a muscle disease among a larger
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Fig. 1. Literature selection Flow Diagram.
non-muscle disease population (2/75 muscular dys-
trophy) [49], this was excluded too. The remaining
twenty-two papers were selected for analysis and are
summarised in Table 2 [9, 36–38, 50–67].
Study sample characteristics
Study-sample numbers ranged from five [56] to
321 participants [65] and included both paediatric
and adult populations. Twelve studies (54%) reported
on a specific NMD entity: Duchenne muscular dys-
trophy (DMD) [37, 54–56, 66]; spinal and bulbar
muscular atrophy (SBMA) [52]; myotonic dystro-
phy type 1 (DM1) [38, 53]; mitochondrial myopathies
[58]; Charcot-Marie-Tooth [60]; Pompe disease [61];
McArdle’s disease [51]; and facioscapulohumeral
muscular dystrophy (FSHD) [63]. The remain-
ing publication-samples were grouped as NMD,
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Fig. 2. Types of direct HPA tools reported. Two studies combined a heart rate (HR) monitor with an additional activity monitor: [1] Yamax
Digi-Walker [57] and [2] StepWatch Activity Monitor (SAM) [37].
including three studies reporting a mixed-diseased
sample involving non-neuromuscular patients [49,
64, 67]. Nine studies (40%) involved a healthy control
group for comparison, referred as “healthy controls”
or “able-bodied” [9, 36–38, 51, 54, 58, 59, 62].
Study design and methodology
Four studies were randomized controlled trials
(RCT) assessing an intervention [52, 53, 63, 67].
Only three studies investigated the validation of an
HPA tool [37, 56, 64]. Two studies reported assessing
the feasibility of these tools as outcome measures for
the primary study aim [49, 54]. The remaining studies
did not specifically test the HPA tool but utilised it for
a secondary aim e.g. Wiles et al. [38]. The primary
aim of this study was to quantify falls and stumbles
in DM1, with a secondary aim of investigating the
correlation between these falls and the patients’ step
count [38].
Eleven studies reported the use of more than one
HPA tool, five of these as a control method (e.g. PA
diaries for PA monitors) or to supplement the end-
points’ report (e.g. Energy Expenditure calculations)
[9, 36, 37, 59, 63].
Direct HPA assessment tools and methodology
Of the selected studies, sixteen reported the use
of a direct HPA tool [9, 36–38, 50, 52, 54, 56–59,
61–64, 67]. Seven of these studies compared against
healthy controls and showed differences between the
groups [9, 36–38, 59, 64, 69]. Characteristics of their
methodology are presented in Table 3 and the eight
different tools identified as direct are presented in
Fig. 2. Full data collection protocol (data criteria for
analysis, definition of non-wear episode and the pro-
cessing of missing data) was only identifiable in three
of the papers [54, 56, 61]. Four papers reported the
use of a patient-reported outcome (i.e. activity diary)
as a quality control method [9, 36, 37, 64].
Patient reported HPA outcomes used in NMD
Fifteen papers reported the use a patient-reported
HPA tool (PRO) (Table 4). The PRO most com-
monly used in this cohort was a type of written
diary of the patient’s activities during the day. The
questionnaires used to measure HPA were: Physi-
cal Activity Scale for Elderly (PASE) [67]; Bouchard
Three-Day Physical Activity Record [51, 55]; Inter-
national Physical Activity Questionnaire (IPAQ)
[58]; EPIC-Norfolk Physical Activity Questionnaire-
2 [59]; Physical Activity Disability Survey-Revised
(PADS-R) [60]; Sickness Impact Profile (SIP) –
mobility and ambulation subscales [62]; Checklist
Individual Strength (CIS) – decreased Physical Activ-
ity subscale [63]; Godin Leisure Time Exercise
Questionnaire (GLTEQ) [65]; and a modified version
of the Baecke Physical Activity Questionnaire [66].
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Table 4
Indirect HPA-tools report and methodology. This table presents all papers identified using an indirect HPA-tool or patient-reported outcome
(PRO) and display the methodological variables reported. Y: information has been reported
Paper Tool name Tool Administration Protocol Summary of Published
description (e.g. respondent, Endpoints References
in detail location, method, etc.) Analysed
McCrory [36] Physical Activity (PA) diary Y Y Y Y
Ollivier [51] Bouchard questionnaire Y Y Y Y
Aitkens [9] Activity records Y Y Y –
Hawker [66] Modified Baecke questionnaire – Y Y Y
McDonald [37] Activity-sleep diary Y Y Y –
Kalkman [62] Subscales of the Sickness Impact Profile (SIP) – Y Y Y
Wintzen [53] PA increment scoring Y Y Y Y
Phillips [59] PA diary Y Y Y Y
Apabhai [58] International PA Questionnaire (IPAQ) – – Y Y
Elsworth [67] PA Scale for Elderly (PASE) Y Y Y –
Rosenberg [65] Godin Leisure Time Exercise Questionnaire
(GLTEQ)
Y Y – Y
Holtebekk [50] PEACH project questionnaire Y – Y Y
Voet [63] Decreased PA subscale from the Checklist
Individual Strength (CIS)
Y Y Y Y
Elliott [55] Simplified version of Bouchard questionnaire Y Y Y Y
Anens [60] PA Disability Survey-Revised (PADS-R) Y Y Y Y
Two papers reported a third person as the respon-
dent, either the patient’s parents or patient’s next of
kin [53, 55], whereas two papers did not provide any
details about their methodology [58, 66].
Evidence-based background of HPA assessment
tools previously used in NMD
A selection of ten systematic reviews appropri-
ate to this topic, and published between 2011 and
2016, were reviewed by the authors in search of addi-
tional evidence to back up each tool identified [13, 22,
28, 29, 34, 35, 69–72]. Validation studies were most
reported in Cerebral Palsy (CP) for paediatrics and
Multiple Sclerosis (MS) for adults and only McDon-
ald et al.’s StepWatch validation study in DMD [37]
was identified as an NMD-population paper; reported
by Oftedal et al. [35].
From the seven identified direct HPA tools, six
have been mentioned in previous systematic reviews:
ActiGraph; StepWatch; Actical; and Yamax; Acti-
cal and SenseWear ™ Pro3 [13, 22, 28, 29, 34,
35, 69–73]. The most reported endpoints have been:
energy expenditure (EE); physical activity levels
(PAL); and step count [29]. Table 5 condenses the
validity evidence behind the direct tools identified
in this review and ten different PROs have been
described in Table 6. The reviewers identified at
least one study comparing each PRO to an objec-
tive tool; three used double-labelled water (DLW)
[74–76], twelve against an accelerometer [77–89] and
one against a HR-monitor [83].
DISCUSSION
This systematic review examines previous studies
measuring habitual physical activity (HPA) in people
affected with neuromuscular disorders (NMD). This
report highlights that HPA assessment in this popula-
tion has been carried out in an increasing number of
studies over recent years, but is still in its infancy as
compared to populations affected by more common
conditions such as diabetes, both in the number of
studies and in the number of patients included.
The first point of note was the use of wide
and overlapping terminology to describe activity.
Differences between ‘physical activity’, ‘exercise’,
‘physical fitness’ [40], ‘performance’ and ‘capacity’
[14] were not always clear. This led to the exclu-
sion of a large number of papers in the screening
process. More accurate distinction of these terms
would have allowed for a more precise identifica-
tion of outcome measures and facilitated comparisons
between publications. Caspersen et al. [40] explain
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the difference between physical activity and exer-
cise, where exercise includes an element of structure
and planning. Physical fitness refers to the attributes
someone has to achieve for either one or both of
them (i.e. strength, endurance and flexibility). The
difference between capacity and performance has
been introduced before and is based on the ICF
terminology [14].
The rationale for measuring HPA (directly or indi-
rectly) in the studies reviewed was rarely explained
in detail. Some studies report assessing a behavioural
pattern whilst others assessed a dose-response effect
to an intervention. The materials and methodology
used were also heterogeneous. This variability made
comparisons between results and the drawing of spe-
cific conclusions difficult. Nonetheless, it is possible
to conclude that PA levels and patterns of NMD sub-
jects differ significantly from the matched healthy
controls [9, 36–38, 51, 54, 58, 59, 64].
Despite reviewing a large number of publications
only three papers allowed for comparisons between
direct and indirect methods [58, 63, 69]. Kalkman
et al. [69] reported a relationship between the Sick-
ness Impact Profile (SIP) scores for mobility and
ambulation and the actometer activity reports in a
mixed NMD cohort. Both tools strongly correlated to
the PA-dependent variables of fatigue and functional
impairment. However when the Myotonic Dystrophy
patients were analysed independently, the correla-
tion with the fatigue score was lost. Apaphabi et al.
[58] reported a moderate association between subjec-
tive PA reports obtained from the IPAQ with those
obtained from the SenseWear Armband; however,
the r-values provided are not strong (0.25 to 0.35).
Finally, Voet et al. [63] provided a tangible exam-
ple of a possible risk faced when only utilising one
assessment method. In this study, the aerobic exer-
cise group (AET) showed increased physical activity
levels when measured directly (actometer), but no
significant changes were reported on the PRO (CIS-
reduced PA questionnaire), which, if used alone,
would have missed these changes. On the other
hand, the actometer, if considered in isolation, might
have led to overestimated conclusions as the results
might not reflect the patient’s perception of activity
levels.
Of the 22 papers reviewed, five reported esti-
mations of Energy Expenditure (EE) and Physical
Activity Levels (PAL) following previously pub-
lished methodologies [9, 36, 51, 55, 139]. However,
the presumed validity and reliability of these methods
do not always translate into a disease population in
particular due to the physiological differences in the
cardiovascular and respiratory systems. Only three
studies presented clearer attempts to validate the
device used in the particular population investigated
beforehand or attached to their HPA investigation [37,
56, 64]. Three other studies combined tools to pro-
vide information from one tool that could support the
other, like an activity diary combined with a heart rate
monitor [9, 37, 59].
Only two studies commented on both the strengths
and barriers of the tools presented, allowing the reader
to get a better idea of what to expect from these and
the possible limitations of the results [37, 56]. Tool
limitations that can resume in a loss of data or a higher
inter-rater variability should be considered in advance
as these might impact on study logistics and sample
estimations.
It is important to emphasize that the reported
outcomes and devices presented and discussed in
this paper represent only those identified through
the literature search; however, this is by no means
an exhaustive list and does not cover some of
the other options currently available and that have
been used in other diseases or epidemiology stud-
ies [13, 29, 69, 73]. Still, it certainly presents a
wider variety that the one discussed in 2007 at the
TREAT-NMD meeting on PA monitoring in NMD
[12], which emphasizes the growing interest in exper-
imenting with these types of tools. Currently, the
authors are aware of ongoing clinical trials in NMDs
using more modern tools such as: ActiGrapha and
GeneActivb accelerometers in DM1; GeneActivc in
mitochondrial diseases and in idiopathic inflamma-
tory myopathies, the StepWatch Activity Monitord
and ActiMyoe in DMD [140] and MoveMonitorf in
myasthenia gravis. These well-controlled trials usu-
ally employ direct along with indirect measures and
will contribute to a growing body of evidence for
the use of these tools in clinical NMD research.
Despite the use of HPA devices being at an early
phase in NMDs, lessons learnt in larger clinical
groups with movement impairments are likely to
be transferrable to the measurement of HPA in
NMDs [1].
a ClinicalTrials.gov Identifier: NCT02858908
b ClinicalTrials.gov Identifier: NCT02118779
c ClinicalTrials.gov Identifier: NCT02398201
d ClinicalTrials.gov Identifier: NCT00847379
e ClinicalTrials.gov Identifier: NCT02500381, NCT01826474
f ClinicalTrials.gov Identifier: NCT02066519
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IMPLICATIONS AND
RECOMMENDATIONS
Assessing HPA effectively has many advantages
and may allow the identification of subject changes
and day-to-day limitations possibly missed with stan-
dard clinical measures [12]. This was reported for
a study in Parkinson’s disease, where no significant
changes in clinical measures of gait and disease bur-
den over time were seen, but a meaningful reduction
in daily ambulatory activity [141]. Identifying the
appropriate tool and methodology appears equally
important in NMD, not only to generate high-quality
data for research and regulatory purposes, but also to
avoid loss of time and resources through the use of
tools or methods not suitable or informative for this
population.
A few concepts should be considered when mea-
suring HPA: reliability, validity and responsiveness
of the tool to use; feasibility of the research site; and
acceptability of the study participants [18, 142, 143].
Ideally, the selected tool should have as much evi-
dence as possible supporting these for the targeted
population or similar cohorts as several studies have
encountered barriers when assessing participants
with altered movement patterns or physiology. The
following examples have relevant learning points:
1. McDonald et al.’s findings regarding heart rate
(HR) adaptations to activity in DMD patients
compared to controls demonstrate how estab-
lished formulas to estimate EE or PAL based on
HR cannot directly translate to a disease group
[37].
2. Indirect tools tend to overestimate physical
activity levels when the respondents are subjects
with flawed physiological responses to activ-
ity [23, 144, 145]. Even the Physical Activity
Scale for Individuals with Physical Disabili-
ties (PASIPD) has shown overestimation when
compared to activity monitors [146].
3. Altered mobility has a big impact on the relia-
bility of motion sensors. Bachasson et al. [147]
and Barak et al.[148] have described altered gait
patterns commonly present in NMD patients,
such as slower gait speed, lower stride fre-
quency, shorter stride length, impaired balance
and low walking endurance. All these variables
will impact on the outputs obtained by activ-
ity monitors where validations were previously
performed with subjects without gait abnormal-
ities [29, 148].
4. Wheel-chair users should be considered inde-
pendently as the circumstances of these subjects
require specific estimations, both for direct
[140, 149] or indirect tools [146]. Ide-
ally, activity monitors will be located on
either trunk or upper limb and PRO should
include activities that can be performed in a
wheelchair.
5. Finally, cognitive impairment should also be
considered when assuming compliance rates
and reliability for both direct and indirect
tools. Certain characteristics, such as a shorter
attention span, memory deficits, and errors in
comprehension and reporting [24, 150] may
interfere with reporting reliability and compli-
ance rates [151].
The authors are not recommending a complete
homogenization of tools or methods utilized for
HPA assessment. This decision will always be sub-
ject to site experience and resources, and most
importantly to the study aims. However, hav-
ing a checklist of considerations prior to HPA
assessment may facilitate the efficiency of the pro-
tocol design and the quality of the study report
(Appendix A). We want to encourage publications
to include enough information to allow for repeata-
bility and a clear understanding of the methodology
used.
CONCLUSION
This review captures the emerging evidence sup-
porting the use of measures that assess habitual
physical activity in NMD and some of the possible
settings where this seems feasible.
Because of the wide variety of options and method-
ology, clinicians and researchers in the field need
to become familiar with the concept and the dif-
ferent constructs within HPA measurement. The
evidence-based knowledge presented here will assist
the clinician and/or researcher to select the most
appropriate tool and methodology for their defined
aim.
Careful consideration of the study aim should
precede choosing a particular tool and method for
assessing HPA. Understanding their strengths and
weaknesses is essential when considering available
resources at the study site. The authors provide a
considerations-checklist for designing a protocol to
assess HPA in NMD in Appendix A.
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APPENDIX A
In this section the authors propose a checklist of considerations to have in mind prior to assessing and report-
ing habitual physical activity (HPA) in neuromuscular disorders (NMD). The following segment summarizes
previously proposed methodological guidelines or strategies for assessing physical activity in population-based
research [1, 41, 142, 152] and has been adapted based on this review’s findings and authors’ previous experience
utilising these tools with this population. A standardized methodology such as the Delphi method should follow
to develop and validate guidelines for HPA assessment in NMD [153].
HPA in NMD considerations checklist
1. Establish the aim for assessing HPA as part of your research question (i.e. What question(s) are
you trying to answer?).
Do you want to:
-Identify any altered activity behaviour present in the specific disease group;
-Identify a specific dose of activity that differentiates patients based on health parameters;
-Measure an intervention effect;
-Measure activity or intervention compliance;
-Establish a surrogate outcome measure for disease progression;
-Identify ‘real-life’ barriers for patients’ best performance;
-Patients’ own perception of their own daily performance or participation?
2. Establish the variable(s) needed to fulfil your question.
Examples:
-Time spent on certain activity like: walking, sedentary time;
-Overall activity levels (PAL) or energetic estimations (EE or METs);
-Characterization of a specific type of activity (e.g. gait speed during walking in daily life, transitions, sleep
patterns);
-Factors associated with HPA (like fatigue, falls, season effect).
3. Establish the level of priority the HPA outcome will have within your study. (i.e. primary or
secondary outcome). This will define the time and resources to be invested.
4. Define your sample criteria.
-Establish your sample characteristics and identify those that may impact on the HPA (i.e. ambulation status,
employment characteristics, level of independence).
5. Establish your sample number.
-It is expected that direct tools will allow a smaller sample but it will still vary depending on the variable to
compare.
-Are there any known factors such as non-compliance or possible loss of data associated with your selected
tool that could impact on your sample number?
6. Identify all possible HPA tools that could fulfil your study needs and identify each one’s strengths
and weaknesses for your study aims and resources.
-Have these been used before in a similar population?
-Would they require a population-specific validation?
-Is there any established standard practice associated with the tool? Is this feasible in your study?
-Are your resources enough to fulfil the tool requirements (i.e. equipment costs, analysis, data rights, human
resources, ethical approvals)?
-Does the research team involved have any previous experience with that tool or similar ones? If not, consider
an interdisciplinary collaboration.
-Would only one tool be enough to fulfil the study aims?
7. Consider the participant’s potential acceptability. This can impact on the overall experience and
final results.
-How many days of assessment (or questions) are really required (i.e. not too short, neither too long)? For
this point, consider previous publications and special characteristics of your cohort (i.e. differences between
paediatrics and adults, differences between employed and unemployed, weekends vs weekdays).
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-Consider staff and patient’s acceptability when defining: [1] body location of the monitor (i.e. comfortable,
easy to collocate, visually acceptable) or [2] the interview process for PRO.
8. Establish all the logistics required to increase the efficiency in your study.
-Establish standard operation procedures applicable for the site or sites involved.
-Consider appointing someone specific or a team for the coordination of the HPA operations.
-Consider staff training prior trial starts.
9.As soon as theHPAoutcome to investigate and theHPA tool to use havebeen established, define the
exact methodology to follow and to report as follows:
Direct (objective) HPA-tools Indirect (reported outcomes) HPA-tools
1. Rationale behind the outcome. 1. Rationale behind the outcome.
2. Validity and reliability available and background (references)
supporting the tool and methodology selected.
2. Validity and reliability available and background (references)
supporting the tool selected.
3. Established methodology: i.e. body-placement location, number
and type of days, number of hours per day.
3. Established methodology: i.e. location (clinic or home),
respondent (patient, carer, researcher), format (electronic, paper).
4. Definition of wear and non-wear periods. 4. Specific management procedures for missing data.
5. Definition of variables presented and background (references)
for their use.
5. Definition of summary variables to report (and references if
applicable).
6. Compliance criteria to include for analysis.
7. Specific management of missing or invalid data.
